glp 1 agonist weight loss GLP-1 medications for GLP-1 Personalized Treatment for Weight

Official supply shortages persisted for most of 2024, as surging demand for AOMs continued to outstrip product supply, despite limited reimbursement, which presented an opportunity quickly seized upon by U.S

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

The magnitude of the benefits of GLP-1RA and SGLT-2 inhibitors on MACE are similar, ranging from 12 to 14% reduction of risk, but only GLP-1RA may reduce the risk of stroke

Heads of State adopted a new Political Declaration under the 2030 Agenda for Sustainable Development - to reduce premature NCD mortality by one-third by 2030

Find out everything about this - if its true and worth all the hype.

GLP-1 medications are a game changer for weight loss, but have serious health concerns